Published in J Gen Intern Med on January 01, 2012
Ethics and best practice guidelines for training experiences in global health. Am J Trop Med Hyg (2010) 5.05
Tuberculosis among participants in an academic global health medical exchange program. J Gen Intern Med (2011) 0.98
Trainee safety in global health. J Gen Intern Med (2011) 0.95
Medical students in developing countries: some benefits for sure but a mixture of risks. J Gen Intern Med (2011) 0.87
Medical students in developing countries. J Gen Intern Med (2011) 0.87
The limitations of "vulnerability" as a protection for human research participants. Am J Bioeth (2004) 14.06
Focused evolution of HIV-1 neutralizing antibodies revealed by structures and deep sequencing. Science (2011) 7.92
Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9. Nature (2011) 7.20
Patients' views on identifiability of samples and informed consent for genetic research. Am J Bioeth (2008) 5.73
Dealing with the long-term social implications of research. Am J Bioeth (2011) 5.41
Community-acquired bloodstream infections in Africa: a systematic review and meta-analysis. Lancet Infect Dis (2010) 5.32
Research ethics recommendations for whole-genome research: consensus statement. PLoS Biol (2008) 5.24
Ethics and best practice guidelines for training experiences in global health. Am J Trop Med Hyg (2010) 5.05
Medical and nursing students' television viewing habits: potential implications for bioethics. Am J Bioeth (2008) 4.94
A national survey of provisions in clinical-trial agreements between medical schools and industry sponsors. N Engl J Med (2002) 4.42
Analysis of a clonal lineage of HIV-1 envelope V2/V3 conformational epitope-specific broadly neutralizing antibodies and their inferred unmutated common ancestors. J Virol (2011) 4.06
Oversight of human participants research: identifying problems to evaluate reform proposals. Ann Intern Med (2004) 3.58
Ethical goals of community consultation in research. Am J Public Health (2005) 3.46
Predictors of incomplete adherence, virologic failure, and antiviral drug resistance among HIV-infected adults receiving antiretroviral therapy in Tanzania. Clin Infect Dis (2007) 3.46
The cost of institutional review boards in academic medical centers. N Engl J Med (2005) 3.06
Bioethics consultation in the private sector. Hastings Cent Rep (2002) 3.01
Evaluation of a dried blood spot HIV-1 RNA program for early infant diagnosis and viral load monitoring at rural and remote healthcare facilities. AIDS (2009) 2.89
The inescapable relevance of bioethics for the practicing clinician. Chest (2006) 2.70
New ISSCR guidelines underscore major principles for responsible translational stem cell research. Cell Stem Cell (2008) 2.61
Protecting research subjects under the waiver of informed consent for emergency research: experiences with efforts to inform the community. Ann Emerg Med (2003) 2.56
Ethical considerations for short-term experiences by trainees in global health. JAMA (2008) 2.48
Polyclonal B cell responses to conserved neutralization epitopes in a subset of HIV-1-infected individuals. J Virol (2011) 2.42
Invasive non-Typhi Salmonella disease in Africa. Clin Infect Dis (2009) 2.40
Global health. Fifty years of U.S. embargo: Cuba's health outcomes and lessons. Science (2010) 2.30
Short-term global health research projects by US medical students: ethical challenges for partnerships. Am J Trop Med Hyg (2010) 2.29
Sensitivity and specificity of typhoid fever rapid antibody tests for laboratory diagnosis at two sub-Saharan African sites. Bull World Health Organ (2011) 2.12
Typhoid Fever and the challenge of nonmalaria febrile illness in sub-saharan Africa. Clin Infect Dis (2012) 2.06
A text message-based intervention to bridge the healthcare communication gap in the rural developing world. Technol Health Care (2010) 1.99
The Presidential Bioethics Commission's database of human subjects research. IRB (2013) 1.98
Validation, performance under field conditions, and cost-effectiveness of Capillus HIV-1/HIV-2 and determine HIV-1/2 rapid human immunodeficiency virus antibody assays using sequential and parallel testing algorithms in Tanzania. J Clin Microbiol (2008) 1.94
Universal antiretroviral therapy for HIV infection: should US treatment guidelines be applied to resource-limited settings? Clin Infect Dis (2013) 1.92
Two distinct broadly neutralizing antibody specificities of different clonal lineages in a single HIV-1-infected donor: implications for vaccine design. J Virol (2012) 1.86
Informed consent in a clinical trial of a novel treatment for rheumatoid arthritis. Arthritis Rheum (2003) 1.86
The OHRP and SUPPORT. N Engl J Med (2013) 1.78
Global burden of invasive nontyphoidal Salmonella disease, 2010(1). Emerg Infect Dis (2015) 1.74
Who tests, who doesn't, and why? Uptake of mobile HIV counseling and testing in the Kilimanjaro Region of Tanzania. PLoS One (2011) 1.73
Ethics in human subjects research: do incentives matter? J Med Philos (2004) 1.70
Measuring trust in medical researchers. Med Care (2006) 1.69
Chikungunya and dengue fever among hospitalized febrile patients in northern Tanzania. Am J Trop Med Hyg (2012) 1.68
Q fever, spotted fever group, and typhus group rickettsioses among hospitalized febrile patients in northern Tanzania. Clin Infect Dis (2011) 1.66
Cost-effectiveness of free HIV voluntary counseling and testing through a community-based AIDS service organization in Northern Tanzania. Am J Public Health (2005) 1.65
Study of the media's potential influence on prospective research participants' understanding of and motivations for participation in a high-profile phase I trial. J Clin Oncol (2002) 1.64
What patients say about medical research. IRB (1999) 1.63
Views of potential research participants on financial conflicts of interest: barriers and opportunities for effective disclosure. J Gen Intern Med (2006) 1.63
Back to the rough ground: working in international HIV prevention as ethical debates continue. IRB (2003) 1.62
Do patients treated with dignity report higher satisfaction, adherence, and receipt of preventive care? Ann Fam Med (2005) 1.62
Vaccinia virus encodes a previously uncharacterized mitochondrial-associated inhibitor of apoptosis. Proc Natl Acad Sci U S A (2003) 1.58
Establishment of haematological and immunological reference values for healthy Tanzanian children in Kilimanjaro Region. Trop Med Int Health (2010) 1.56
Permission and assent for clinical research in pediatric anesthesia. Anesth Analg (2002) 1.56
Ethical and practical issues associated with aggregating databases. PLoS Med (2008) 1.53
Treating hepatitis C in lower-income countries. N Engl J Med (2014) 1.52
Community hospital oversight of clinical investigators' financial relationships. IRB (2009) 1.51
Invasive Salmonella infections in areas of high and low malaria transmission intensity in Tanzania. Clin Infect Dis (2013) 1.51
Patient reactions to confidentiality, liability, and financial aspects of informed consent in cardiology research. Circ Cardiovasc Qual Outcomes (2010) 1.50
Leptospirosis among hospitalized febrile patients in northern Tanzania. Am J Trop Med Hyg (2011) 1.49
Applying justice in clinical trials for diverse populations. Clin Trials (2007) 1.46
Predicting virologic failure among HIV-1-infected children receiving antiretroviral therapy in Tanzania: a cross-sectional study. J Acquir Immune Defic Syndr (2010) 1.44
Policies of academic medical centers for disclosing financial conflicts of interest to potential research participants. Acad Med (2006) 1.43
Untying the Gordian knot: policies, practices, and ethical issues related to banking of umbilical cord blood. J Clin Invest (2005) 1.43
The myxoma poxvirus protein, M11L, prevents apoptosis by direct interaction with the mitochondrial permeability transition pore. J Exp Med (2002) 1.39
Implications of universal screening for HIV infection. BMJ (2013) 1.37
The vaccinia virus F1L protein interacts with the proapoptotic protein Bak and inhibits Bak activation. J Virol (2005) 1.34
Early versus delayed fixed dose combination abacavir/lamivudine/zidovudine in patients with HIV and tuberculosis in Tanzania. AIDS Res Hum Retroviruses (2009) 1.32
The Bio-PIN: a concept to improve biobanking. Nat Rev Cancer (2011) 1.32
Antimicrobial susceptibility to azithromycin among Salmonella enterica isolates from the United States. Antimicrob Agents Chemother (2011) 1.31
Beyond "compliance": the role of institutional culture in promoting research integrity. Acad Med (2010) 1.30
Fertility patients' views about frozen embryo disposition: results of a multi-institutional U.S. survey. Fertil Steril (2008) 1.30
Preventive misconception: its nature, presence, and ethical implications for research. Am J Prev Med (2007) 1.30
Health technologies and innovation in the global health arena. N Engl J Med (2011) 1.29
Near death experiences: poxvirus regulation of apoptotic death. Virology (2006) 1.27
Population-based surveillance of typhoid fever in Egypt. Am J Trop Med Hyg (2006) 1.26
Regulatory challenges for the resuscitation outcomes consortium. Circulation (2008) 1.26
Variability in the costs of institutional review board oversight. Acad Med (2006) 1.25
Toward protecting the safety of participants in clinical trials. Control Clin Trials (2003) 1.23
Effects of disclosing financial interests on attitudes toward clinical research. J Gen Intern Med (2008) 1.23
Improving informed consent: the medium is not the message. IRB (2004) 1.23
Controversy and quality improvement: lingering questions about ethics, oversight, and patient safety research. Jt Comm J Qual Patient Saf (2008) 1.22
Brucellosis in low-income and middle-income countries. Curr Opin Infect Dis (2013) 1.20
Granzyme B-induced apoptosis requires both direct caspase activation and relief of caspase inhibition. Immunity (2003) 1.20
Ethical issues in identifying and recruiting participants for familial genetic research. Am J Med Genet A (2004) 1.20
Disclosing conflicts of interest in clinical research: views of institutional review boards, conflict of interest committees, and investigators. J Law Med Ethics (2006) 1.19
An intervention to improve cancer patients' understanding of early-phase clinical trials. IRB (2009) 1.18
Disclosure of cancer diagnosis and prognosis in Northern Tanzania. Soc Sci Med (2003) 1.17
Lopinavir/ritonavir monotherapy after virologic failure of first-line antiretroviral therapy in resource-limited settings. AIDS (2012) 1.16
Developing ethics guidance for HIV prevention research: the HIV Prevention Trials Network approach. J Med Ethics (2010) 1.15
Conducting empirical research on informed consent: challenges and questions. IRB (2004) 1.14
Initial HIV-1 antigen-specific CD8+ T cells in acute HIV-1 infection inhibit transmitted/founder virus replication. J Virol (2012) 1.13
Challenges to effective research in acute trauma resuscitation: consent and endpoints. Shock (2011) 1.13
Transient facial swellings in a patient with a remote African travel history. J Travel Med (2012) 1.13
Mycobacterium sherrisii sp. nov., a slow-growing non-chromogenic species. Int J Syst Evol Microbiol (2010) 1.12
The vaccinia virus protein F1L interacts with Bim and inhibits activation of the pro-apoptotic protein Bax. J Biol Chem (2006) 1.12
Establishing HIV treatment as prevention in the HIV Prevention Trials Network 052 randomized trial: an ethical odyssey. Clin Trials (2012) 1.11
Proteomic screening of variola virus reveals a unique NF-kappaB inhibitor that is highly conserved among pathogenic orthopoxviruses. Proc Natl Acad Sci U S A (2009) 1.11
Persistent Ebola Virus in the Eye. N Engl J Med (2015) 1.10
Characteristics of HIV voluntary counseling and testing clients before and during care and treatment scale-up in Moshi, Tanzania. J Acquir Immune Defic Syndr (2009) 1.09
Reflecting on short-term international service-learning trips. Acad Med (2013) 1.08